COVID-19 (coronavirus): resources for the oral and dental care team

Coronavirus disease (COVID-19) is caused by a new strain of Coronavirus (SARS-CoV-2) discovered in 2019, and not previously identified in humans. Common symptoms include fever, cough, and shortness of breath. On March 11, the World Health Organization (WHO) announced the current COVID-19 outbreak as a pandemic.

For authoritative information about the science underpinning the epidemic, see the UK Research and Innovation Coronavirus resource.

Cochrane Oral Health are collecting information and guidance from international professional dental bodies. At this time, it is more important than ever to work together and the Global Evidence Ecosystem for Oral Health (GEEOH) will continue to do this.

We will publish links on this page as they become available. If you would like us to link to a resource that is not currently on our list, please contact us.

Guidance for the oral and dental care team from our Global Alliance and GEEOH partners:

Other guidance for the oral and dental care team:

Cochrane evidence

1. The Cochrane Library: Cochrane as a whole is undertaking a comprehensive programme of work to provide evidence for those caring for Covid-19 patients, and has made the Cochrane Library temporarily freely available to all

2. Cochrane resources and news: Cochrane has an extensive collection of resources related to COVID-19 and these are available here.

3. Cochrane Special Collections relating to coronavirus have been developed:

4. Cochrane COVID Rapid Reviews. Cochrane is engaging with a range of stakeholders to build a bank of important questions emerging from the COVID-19 pandemic, including the World Health Organization (WHO), the Australian National Health and Medical Research Council (NHMRC), the UK National Institute for Health Research (NIHR) and the Brazilian Ministry of Health. The first 60 questions underwent a very early prioritisation process to allow work to begin immediately on urgent reviews. The remaining questions will undergo a rapid prioritisation process with stakeholders. The list of suggested topics can be found here. Some of these are underway, others will be prioritized for later completion.  

5. COVID-19 Consumer rapid response group. Cochrane are recruiting consumers to be a part of a COVID-19 consumer rapid response group. Cochrane are particularly looking for healthcare consumers who have experience of helping with Cochrane or other systematic reviews, and have experience of COVID-19 either as a patient, an informal carer or as someone at high risk of catching the disease. Find out more here

Cochrane rapid reviews published so far:

General guidance on COVID-19:

COVID-19 trials in-progress and data from trials

Cochrane has launched a COVID-19 trial register to support rapid evidence synthesis, find it here.

For a register of COVID-19-related trials that are in-progess and may – or may not – have yet published results (links are included when results are available) please see Covid-19 TrialsTracker.

Cochrane's partner Vivli is collecting and sharing data from COVID-19-related clinical trials (published data and individual patient data from published and unpublished trials); find out more here.